Finance

Lists
RX:CVE
Biosyent Inc
17,07 CAD
+0,65%
(+0,11) 1D
21-окт., 09:30:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RX...
Open
17,07 CAD
High
17,07 CAD
Low
17,07 CAD
Mkt. cap
196,05 млн
Avg. vol.
7,92 миң
Volume
350,00
Dividend
1,29%
Quarterly dividend
0,06 CAD
Ex-dividend date
2026-ж., 31-авг.
P/E ratio
20,00
52-wk high
17,50 CAD
52-wk low
10,65 CAD
EPS
0,85 CAD
Beta
0,28
Shares outstanding
11,31 млн
No. of employees
0
Open
17,07 CAD
High
17,07 CAD
Low
17,07 CAD
Mkt. cap
196,05 млн
Avg. vol.
7,92 миң
Volume
350,00
Dividend
1,29%
Quarterly dividend
0,06 CAD
Ex-dividend date
2026-ж., 31-авг.
P/E ratio
20,00
52-wk high
17,50 CAD
52-wk low
10,65 CAD
EPS
0,85 CAD
Beta
0,28
Shares outstanding
11,31 млн
No. of employees
0
News stories
From web sources and news partners
About Biosyent Inc
CEO-
Employees0
Founded1947
HeadquartersМиссисога, Онтарио, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
12,22 млн
9,67 млн
13,91 млн
19,87 млн
Cost of goods sold
2,95 млн
2,23 млн
3,74 млн
5,90 млн
Cost of revenue
2,95 млн
2,23 млн
3,74 млн
5,90 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,84 млн
5,22 млн
6,23 млн
8,83 млн
Operating expense
5,84 млн
5,22 млн
6,72 млн
9,88 млн
Total operating expenses
8,79 млн
7,45 млн
10,46 млн
15,78 млн
Operating income
3,43 млн
2,22 млн
3,45 млн
4,09 млн
Other non operating income
-
-
-
-
EBT including unusual items
3,65 млн
2,48 млн
3,29 млн
3,97 млн
EBT excluding unusual items
3,65 млн
2,48 млн
3,56 млн
4,13 млн
Income tax expense
967,10 миң
486,60 миң
940,48 миң
1,12 млн
Effective tax rate
26,50%
19,63%
28,63%
28,23%
Other operating expenses
-
-
-
-
Net income
2,68 млн
1,99 млн
2,34 млн
2,85 млн
Net profit margin
21,95%
20,59%
16,86%
14,34%
Earnings per share
-
-
-
-
Interest and investment income
231,39 миң
187,77 миң
166,79 миң
94,41 миң
Interest expense
-12,14 миң
-11,48 миң
-31,62 миң
-51,37 миң
Net interest expenses
219,25 миң
176,29 миң
135,18 миң
43,04 миң
Depreciation and amortization charges
-
-
94,11 миң
153,87 миң
EBITDA
3,65 млн
2,41 млн
3,88 млн
5,05 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору